CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that Chairman and Chief Executive Officer Paul R. Gudonis and Chief Financial Officer David Henry will be presenting, as well as meeting with investors, at two upcoming investor conferences. Details for the two conferences are:
31st Annual ROTH Conference at The Ritz
Carlton, Orange County. Presentation on Monday, March 18th
at 8:00 a.m. PDT/11:00 a.m. EDT, PINK – SALON 5.
Oppenheimer’s 29th
Annual Healthcare Conference at The Westin New York Grand Central.
Presentation on Wednesday, March 20th at 10:20 a.m. EDT,
Track 2.
A live webcast of the 31st Annual Roth Conference presentation can be accessed from the Investor Relations page of the Company's website. The webcast and presentation will be archived on the Company's website for 90 days following the event.
About Myomo
Myomo, Inc. is a wearable medical robotics
company that offers expanded mobility for those suffering from
neurological disorders and upper limb paralysis. Myomo develops and
markets the MyoPro product line. MyoPro is a powered upper limb orthosis
designed to support the arm and restore function to the weakened or
paralyzed arms of patients suffering from CVA stroke, brachial plexus
injury, traumatic brain or spinal cord injury, ALS or other
neuromuscular disease or injury. It is currently the only marketed
device that, sensing a patient’s own EMG signals through non-invasive
sensors on the arm, can restore an individual’s ability to perform
activities of daily living, including feeding themselves, carrying
objects and doing household tasks. Many are able to return to work, live
independently and reduce their cost of care. Myomo is headquartered in
Cambridge, Massachusetts, with sales and clinical professionals across
the U.S. For more information, please visit www.myomo.com.
